Jun Yang Selected Research

galactonic acid

6/2015

Systemic alterations in the metabolome of diabetic NOD mice delineate increased oxidative stress accompanied by reduced inflammation and hypertriglyceremia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jun Yang Research Topics

Disease

462	Neoplasms (Cancer) 12/2024 - 07/2002
158	Inflammation (Inflammations) 02/2024 - 03/2006
134	Infections 05/2024 - 07/2002
80	Fibrosis (Cirrhosis) 04/2024 - 01/2006
76	Pain (Aches) 11/2023 - 10/2002
66	Neoplasm Metastasis (Metastasis) 03/2024 - 09/2004
62	Hypertension (High Blood Pressure) 03/2024 - 08/2002
57	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 08/2002
48	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 08/2002
48	Hypoxia (Hypoxemia) 01/2024 - 01/2002
47	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2006
45	Myocardial Infarction 10/2023 - 11/2005
44	Wounds and Injuries (Trauma) 12/2023 - 02/2002
43	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 07/2003
41	Hyperaldosteronism (Conn Syndrome) 12/2024 - 01/2018
40	Carcinogenesis 03/2024 - 10/2003
40	Reperfusion Injury 12/2023 - 12/2004
40	Ischemia 09/2022 - 04/2002
33	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 07/2005
33	Carcinoma (Carcinomatosis) 07/2022 - 07/2002
32	Myocardial Ischemia (Ischemic Heart Diseases) 01/2023 - 09/2005
31	Lung Neoplasms (Lung Cancer) 02/2024 - 02/2005
30	Body Weight (Weight, Body) 05/2024 - 07/2005
30	Type 2 Diabetes Mellitus (MODY) 12/2023 - 12/2004
29	Stroke (Strokes) 11/2023 - 09/2002
27	Infarction (Infarctions) 04/2024 - 04/2002
27	Heart Failure 11/2023 - 01/2006
26	Hemorrhage 10/2023 - 12/2002
25	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 06/2008
25	Sepsis (Septicemia) 04/2024 - 01/2003
24	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 10/2004
23	Obesity 04/2024 - 12/2004
23	Atherosclerosis 03/2024 - 01/2005
22	Pulmonary Arterial Hypertension 03/2024 - 05/2008
22	Stomach Neoplasms (Stomach Cancer) 10/2023 - 05/2003
20	Brain Ischemia (Cerebral Ischemia) 04/2024 - 04/2002
20	Glioma (Gliomas) 02/2024 - 10/2007
20	Insulin Resistance 08/2022 - 10/2006
18	COVID-19 03/2024 - 01/2020
18	Poisoning 12/2023 - 05/2014
18	Hearing Loss (Hearing Impairment) 01/2023 - 08/2011
17	Adenocarcinoma of Lung 12/2023 - 08/2013
17	Hypertrophy 10/2022 - 01/2002
16	Pancreatitis 06/2023 - 05/2002
16	Necrosis 03/2023 - 11/2002

Drug/Important Bio-Agent (IBA)

218	Proteins (Proteins, Gene)FDA Link 04/2024 - 07/2002
123	Biomarkers (Surrogate Marker)IBA 03/2024 - 10/2003
80	CytokinesIBA 04/2024 - 05/2002
63	Epoxide HydrolasesIBA 02/2024 - 01/2009
62	MicroRNAs (MicroRNA)IBA 02/2024 - 01/2010
58	Messenger RNA (mRNA)IBA 06/2023 - 07/2002
53	LipidsIBA 03/2024 - 12/2002
44	EnzymesIBA 04/2024 - 02/2009
39	RNA (Ribonucleic Acid)IBA 04/2024 - 09/2004
35	CollagenIBA 04/2024 - 02/2002
34	Therapeutic UsesIBA 11/2023 - 07/2003
33	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 08/2002
32	Peptides (Polypeptides)IBA 04/2022 - 12/2002
31	Fatty Acids (Saturated Fatty Acids)IBA 02/2024 - 12/2009
30	Long Noncoding RNAIBA 02/2024 - 05/2012
30	AcidsIBA 04/2023 - 05/2007
28	AldosteroneIBA 12/2024 - 10/2010
28	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2024 - 04/2003
26	Small Interfering RNA (siRNA)IBA 11/2023 - 08/2009
26	Interleukin-6 (Interleukin 6)IBA 11/2023 - 02/2003
25	Indicators and Reagents (Reagents)IBA 04/2024 - 02/2004
23	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 09/2002
23	SodiumIBA 01/2023 - 03/2003
21	Transcription Factors (Transcription Factor)IBA 01/2024 - 09/2003
21	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024 - 06/2003
20	Anti-Bacterial Agents (Antibiotics)IBA 05/2024 - 09/2005
20	Phosphotransferases (Kinase)IBA 02/2024 - 01/2003
20	AntioxidantsIBA 01/2024 - 11/2004
20	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2023 - 05/2002
20	Androgen Receptors (Androgen Receptor)IBA 07/2022 - 04/2006
19	LigandsIBA 06/2023 - 04/2006
19	Caspase 3 (Caspase-3)IBA 02/2023 - 02/2003
19	Arginine Vasopressin (Argipressin)IBA 01/2019 - 01/2006
18	ReninIBA 12/2024 - 02/2012
18	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 07/2023 - 01/2015
18	salicylhydroxamic acid (SHAM)IBA 04/2022 - 01/2003
17	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 05/2012
17	CateninsIBA 01/2024 - 12/2010
17	CalciumIBA 01/2024 - 03/2003
17	AndrogensIBA 11/2021 - 08/2002
17	Toll-Like Receptor 4IBA 01/2021 - 01/2008
16	VaccinesIBA 03/2024 - 01/2007
16	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 02/2024 - 12/2010
16	Epoxy Compounds (Epoxides)IBA 11/2023 - 01/2013
16	InterferonsIBA 10/2021 - 04/2007
15	Paclitaxel (Taxol)FDA LinkGeneric 05/2024 - 03/2010

Therapy/Procedure

266	Therapeutics 03/2024 - 08/2002
59	Drug Therapy (Chemotherapy) 05/2024 - 08/2002
46	Radiotherapy 01/2024 - 01/2003
33	Moxibustion 01/2024 - 02/2008
28	Immunotherapy 03/2024 - 01/2014
20	Aftercare (After-Treatment) 01/2024 - 11/2006
19	Length of Stay 04/2024 - 10/2010
19	Transplantation 08/2023 - 04/2006
17	Hematopoietic Stem Cell Transplantation 11/2023 - 02/2011